Brief: Strides Pharma Science Gets USFDA Approval For Mycophenolate Mofetil For Oral Suspension
30/08/2023 06:04
Aug 30 (Reuters) - Strides Pharma Science Ltd SRID.NS :
* RECEIVES USFDA APPROVAL FOR MYCOPHENOLATE MOFETIL FOR ORAL
SUSPENSION
Source text for Eikon: ID:nBSEbDHp7p
Further company coverage: SRID.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees